Regulatory responses to kavalactone toxicity have varied globally. Some countries have imposed restrictions or bans on kava-containing products, while others allow their sale with specific labeling requirements. The regulatory stance often reflects the balance between the traditional use of kava and the documented risks of adverse effects.
